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ABSTRACT 51 
Background 52 
Maximal cardiopulmonary exercise testing is recommended on an annual basis for children 53 
with cystic fibrosis (CF), due to a clinically useful prognostic information provided by maximal 54 
oxygen uptake (V̇O2max). However, not all patients are able, or willing, to reach V̇O2max, and 55 
therefore submaximal alternatives are required. This study explored the validity of the oxygen 56 
uptake efficiency slope (OUES) as a submaximal measure of V̇O2max in children and 57 
adolescents with CF. 58 
Methods 59 
Data were collated from 72 cardiopulmonary exercise tests (36 CF, 36 controls), with OUES 60 
determined relative to maximal and submaximal parameters of exercise intensity, time and 61 
individual metabolic thresholds. Pearson’s correlation coefficients, independent t-tests and 62 
factorial ANOVAs were used to determine validity.   63 
Results 64 
Significant (p < 0.05) correlations with V̇O2max were observed for most expressions of OUES, 65 
but were consistently weaker in CF (r = 0.30 – 0.47) when compared to CON (r = 0.58 – 0.89). 66 
Mean differences for all OUES parameters between groups were not significant (p > 0.05). 67 
When split by V̇O2max tertiles, minimal significant differences were found between, and within, 68 
groups for OUES, indicating poor discrimination of V̇O2max.  69 
Conclusions 70 
The OUES is not a valid (sub)maximal measure of V̇O2max in children and adolescents with 71 
mild-to-moderate CF. Clinicians should continue to use maximal markers (i.e. V̇O2max) of 72 
exercise capacity.  73 
 74 
 75 
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1. INTRODUCTION 101 
 102 
Previous research indicates the benefit of high levels of cardiorespiratory fitness, as 103 
characterised by maximal oxygen uptake (V̇O2max), for young people with cystic fibrosis (CF).  104 
A high V̇O2max is associated with an improved quality of life 1, reduced risk of hospitalisation 105 
for pulmonary exacerbations 2 and reduced mortality risk 3. Consequently, individuals with CF 106 
are advised to increase their exercise and habitual physical activity levels, with regular maximal 107 
cardiopulmonary exercise testing (CPET) also recommended and endorsed by the European 108 
CF Society 4 and European Respiratory Society, to monitor changes in their aerobic fitness 109 
status.  110 
 111 
However, assessing V̇O2max requires patients to provide a maximal physical effort and is thus 112 
considered an ‘effort dependent’ test. Motivation, discomfort, excessive dyspnoea, chronic 113 
fatigue and naivety towards protocols may make patients with CF more unwilling or unable to 114 
reach volitional exhaustion and their V̇O2max. Therefore, physiological markers of aerobic 115 
fitness that can be attained during submaximal regions of a CPET can be particularly useful 5.  116 
 117 
One such marker is the oxygen uptake efficiency slope (OUES), a submaximal, effort-118 
independent parameter describing the relationship between V̇O2 and the common logarithm of 119 
minute ventilation (V̇E) 6. Given the curvilinear relationship between ventilation and oxygen 120 
uptake during incremental exercise, it is difficult to model and therefore normalisation of 121 
ventilation (i.e. logVE) allows for direct comparison between tests (and groups). A higher value 122 
for the OUES indicates a greater ventilatory efficiency. The OUES has been shown to 123 
significantly and positively correlate with V̇O2max in healthy children 7 and children with heart 124 
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disease 6, indicating its potential as a submaximal surrogate of aerobic fitness in paediatric 125 
groups.  126 
 127 
Despite OUES appearing to be a valid determinant of exercise tolerance in adults with CF 8, 128 
evidence for its use in children and adolescents with CF requires further verification. Only one 129 
study has previously sought to validate the OUES as an effort-independent marker of V̇O2max 130 
in a paediatric population with mild-to-moderate CF 
9. This study calculated OUES at 100%, 131 
75% and 50% of the test duration and concluded it invalid, due to the observed moderate 132 
positive correlations between the OUES and V̇O2max (r = 0.41 – 0.54). Furthermore, despite 133 
decreased V̇O2max in children with CF, the OUES was unable to differentiate fitness status 134 
between children with, and without CF; leading authors to conclude the invalidity of OUES in 135 
this patient group. However, there are multiple methodological weaknesses to this study. 136 
Firstly, utilising CPET time to exhaustion (TTE) as a measure of intensity may be flawed, as it 137 
does not account for variances in individual metabolic thresholds. As the presence of reduced 138 
maximal capacity 10 and an altered oxygen cost of exercise 11 have been demonstrated in 139 
individuals with CF, it is conceivable that patients in this previous study 9 may be exercising 140 
at differing relative exercise intensities (i.e. as a percentage of V̇O2max), and even within 141 
differing intensity domains, despite being matched for exercise duration. Secondly, there was 142 
a lack of appropriate normalisation for the influence of body size, with authors utilising ratio-143 
standard scaling, whereas previous research has shown this to be insufficient at removing 144 
residual effects of body size from OUES 12.  145 
 146 
Given aforementioned issues associated with previous research 9, OUES should instead be 147 
assessed at individually determined parameters of relative exercise intensity (%V̇O2max) and 148 
domain thresholds, such as the gas exchange threshold (GET) and respiratory compensation 149 
Page 7 of 27 
 
point (RCP) 13, alongside utilising allometric scaling protocols to ensure a size-free analysis of 150 
OUES 12.   151 
 152 
Therefore, the purpose of this study was to examine correlates of allometrically-scaled OUES 153 
with V̇O2max, and to systematically investigate differences in the OUES between children with 154 
CF and healthy controls (CON) at appropriately matched parameters of relative exercise 155 
intensity (%V̇O2max), TTE and individual metabolic boundaries (GET and RCP). In addition, 156 
the study will examine whether the OUES can differentiate between patients of differing 157 
aerobic fitness statuses vs. healthy matched controls and, therefore, its suitability as a 158 
submaximal surrogate for V̇O2max.  159 
 160 
 161 
 162 
 163 
 164 
 165 
 166 
 167 
 168 
 169 
 170 
 171 
 172 
 173 
 174 
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2. MATERIALS AND METHODS 175 
 176 
2.1 Participants 177 
Data from 45 children and adolescents with CF were considered for inclusion in the current 178 
retrospective analysis. Nine children were excluded due to inadequate data (insufficient, or 179 
missing data, n = 7; insufficient test length, n = 2). Remaining data were subsequently age- and 180 
gender-matched from existing exercise databases of healthy children, resulting in a final sample 181 
of n = 72 (36 CF, 36 CON; 21 males per group; mean age 13.3 ± 2.8 years). All CON children 182 
were screened for contraindications to exercise prior to CPET participation, including 183 
pulmonary disorders and unstable co-morbid asthma.  184 
 185 
As the study was a retrospective analysis of existing data, additional ethics approval was not 186 
required. Ethics approval for data collected was originally approved by South West NHS 187 
Research Ethics and local institutional ethics committees, whereby fully informed written 188 
consent and assent were obtained from parents/guardians and paediatric participants, 189 
respectively.  190 
 191 
2.2 Data Collection 192 
All participants undertook a CPET to volitional exhaustion on an electronically braked cycle 193 
ergometer, to determine V̇O2max and submaximal measures of cardiorespiratory fitness. If 194 
required by patients with CF, bronchodilators were administered prior to CPET. Pulmonary 195 
function was assessed using a hand-held spirometer, with maximal values of forced expiratory 196 
volume in one-second (FEV1) and forced vital capacity (FVC) compared to normative values 197 
14-16. Pubertal status of children was determined as age from peak height velocity (aPHV), using 198 
published equations 17.  199 
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 200 
2.3 Data Analysis 201 
Pulmonary gas exchange and ventilation data were collected breath-by-breath, and 202 
subsequently averaged to 10 second time intervals. Previously described techniques were 203 
utilised to ascertain V̇O2max 18, GET and RCP 13. To ascertain OUES values, linear regressions 204 
were obtained between V̇O2 and the logarithmic transformation of V̇E (logV̇E), using data up to 205 
the following boundaries:  100%, 75% and 50% of TTE (100TTE, 75TTE, 50TTE), 100%, 75% 206 
and 50% of V̇O2max (100V̇O2max, 75V̇O2max, 50V̇O2max), GET and RCP. The time point of 207 
100%V̇O2max also describes 100%TTE – providing eight OUES parameters per participant.  208 
 209 
2.4 Scaling of Data 210 
All OUES values were allometrically scaled to BSA 19, in line with recent recommendations 211 
12. An allometric model was applied to remove residual effects of body size, with OUES scaled 212 
to BSA1.40. V̇O2max was not scaled using allometric procedures as ratio-standard scaling 213 
sufficiently removed residual effects of body size.  214 
 215 
2.5 Statistical Analyses 216 
Descriptive data are reported as mean (± standard deviation (SD)) unless otherwise stated. 217 
Pearson’s correlation coefficients were calculated between V̇O2max and each of the eight 218 
normalised OUES values, to identify if the two variables are significantly related. Independent 219 
samples t-tests were also performed to identify differences between CF and CON for all 220 
variables, and identify the impact of disease status upon OUES. Finally, factorial ANOVAs 221 
were conducted to identify the interaction between V̇O2max status, split by tertile 3, and disease 222 
status upon V̇O2max and OUES/BSA1.40. Where main or interaction effects were found, pairwise 223 
comparisons using Bonferroni corrections were applied to identify where relationships existed. 224 
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Statistical significance was set at an alpha of 0.05 and Cohen’s thresholds are used to report 225 
effect sizes (ES) and illustrate the magnitudes of the mean difference 20.   226 
 227 
 228 
 229 
 230 
 231 
 232 
 233 
 234 
 235 
 236 
 237 
 238 
 239 
 240 
 241 
 242 
 243 
 244 
 245 
 246 
 247 
 248 
 249 
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3. RESULTS 250 
 251 
3.1 Participant characteristics 252 
Participant characteristics and mean differences between groups are presented in Table 1. 253 
Significant differences were observed between CF and CON for pulmonary function and the 254 
absolute V̇O2 at the GET.  255 
 256 
3.2 Correlation between OUES and V̇O2max 257 
All OUES/BSA1.40 variables significantly correlated with body mass relative V̇O2max, apart 258 
from 50%TTE within the CF group (Table 2).   259 
 260 
3.3 Difference in OUES between CF and CON 261 
Mean values for BSA corrected OUES values were lower, but not significantly, in CF 262 
compared to CON at each threshold (50V̇O2max: 923 ± 273 vs. 992 ± 290; 75V̇O2max: 1088 ± 224 263 
vs. 1153 ± 293; 50TTE: 1019 ± 219 vs. 1091 ± 273; 75TTE: 1101 ± 225 vs. 1182 ± 284; 100V̇O2max 264 
and 100TTE: 1141 ± 257 vs. 1206 ± 267; GET: 958 ± 296 vs. 996 ± 361; RCP: 1148 ± 251 vs. 265 
1189 ± 297; p > 0.05 for all comparisons (range = 0.18 – 0.63); units for all parameters: mL.min-266 
1.logL.-1.m-2.8). Figure 1 represents the data for OUES relative to BSA, according to categories 267 
of duration, intensity and the metabolic thresholds.    268 
 269 
3.4 OUES and fitness tertiles 270 
When the data were split by tertiles according to V̇O2max (Figure 2), a significant difference 271 
was observed between tertiles within both CF (45.7 ± 4.8 vs. 38.0 ± 2.0 vs. 29.5 ± 4.6 mL.kg-272 
1.min-1, respectively) and CON (51.9 ± 5.6 vs. 38.9 ± 2.5 vs. 29.0 ± 6.3 mL.kg-1.min-1, 273 
respectively) groups with regards to aerobic fitness (p < 0.001 for all pairwise comparisons, ES 274 
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= 2.07 – 3.84). However, there was only a significant difference in V̇O2max between CF and 275 
CON in the highest aerobic fitness tertile (p < 0.001, ES = 1.19).  276 
 277 
When split by V̇O2max tertiles, there was no significant difference in OUES/BSA1.40 at 278 
100%TTE (p > 0.05). In CF, at 100%TTE, OUES/BSA1.40 was significantly higher in the 279 
highest (1271 ± 241) relative to the lowest (1020 ± 281) fitness tertile (p = 0.016, ES = 0.96). 280 
The middle tertile (1131 ± 198) was not significantly different between either the highest (p = 281 
0.34, ES = 0.63) or lowest tertile (p = 0.62, ES = 0.46). By comparison, in the CON group 282 
significant differences were found between the highest (1441 ± 211) and lowest (957 ± 206; p 283 
< 0.001, ES = 2.32), between the middle (1219 ± 108) and the lowest (p = 0.011, ES = 1.59) 284 
and middle and highest (p = 0.041, ES = 1.32; Figure 3) tertiles. 285 
 286 
There was no significant difference in OUESGET/BSA
1.40 between the groups (p > 0.05). When 287 
OUESGET/BSA
1.40 was split by aerobic fitness tertiles, a significant difference was only found 288 
within the CON group between the highest (1221 ± 336) and lowest tertiles (798 ± 273, p = 289 
0.005, ES = 1.38). The middle tertile (952 ± 356) was not significantly different to either the 290 
highest (p = 0.114, ES = 0.78) or lowest tertile (p = 0.712, ES = 0.49). In the CF group, no 291 
significant differences were found between any tertiles (highest: 1017 ± 273; middle: 1006 ± 292 
324; lowest: 854 ± 290, all p > 0.61, ES = 0.04 – 0.58). No significant differences between 293 
groups were observed for each tertile (all p > 0.11, ES = 0.16 – 0.64; Figure 3).   294 
 295 
 296 
 297 
 298 
 299 
Page 13 of 27 
 
4. DISCUSSION 300 
 301 
The primary purpose of this study was to investigate the validity of the OUES as a submaximal 302 
alternative to V̇O2max in young people with CF – utilising a larger CF cohort than previous 303 
research 9,21. Specifically, we comprehensively compared differences in the OUES, when 304 
appropriately normalised for BSA 12, between children and adolescents with mild-to-moderate 305 
CF and their healthy peers, at parameters of time and relative exercise intensity. Although 306 
OUES was associated with V̇O2max in both CF and CON groups, coefficients were consistently 307 
smaller in CF. Despite differences in these correlations, statistically significant differences in 308 
OUES could not be found between groups, regardless of whether it was standardised to 309 
percentage of V̇O2max, test duration or submaximal metabolic thresholds. Furthermore, OUES 310 
could not discriminate fitness status within, and between, groups. Taken collectively, these 311 
observations suggest OUES does not provide a valid surrogate of V̇O2max in children and 312 
adolescents with CF, supporting previous findings 9. 313 
 314 
In this present study, significant correlations were observed between body-mass relative 315 
V̇O2max and the majority of BSA corrected OUES thresholds, except at 50%TTE in the CF group. 316 
The locations of significance are identical to the only previous OUES study in children with a 317 
similar severity of CF during incremental cycling exercise, with magnitudes of correlations in 318 
the CF and CON groups corroborating previous work 9 as CON shows larger effect sizes (r = 319 
0.58 – 0.89) in comparison to the medium effect sizes (r = 0.30 – 0.47) of the CF cohort. As 320 
the correlation coefficients in the CF groups suggest a shared variance (R2) of between 9 and 321 
22% (unlike 34 – 79% in CON), these results suggest that despite their association, OUES may 322 
not be a viable surrogate for V̇O2max. 323 
   324 
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Despite positive correlations with V̇O2max, no mean differences in OUES were observed 325 
between CF and CON at each parameter (of intensity, time and metabolic thresholds) – a 326 
finding contrasting previous adult and paediatric studies assessing OUES in independent 327 
groups 6-8,22,23. However, it could be argued that since a significantly lower V̇O2max was not 328 
observed in CF versus CON in the present study, in contrast to previous findings 10,21, a 329 
recruitment bias may be present. The lack of differences between groups may be due to 330 
deconditioning of control participants (as opposed to increased fitness in CF), with V̇O2max 331 
being 10 ml.kg-1.min-1 lower in the current study, when compared to previous research 9. 332 
Consequently, it would also be expected that no differences in OUES would be observed. 333 
However, factorial ANOVAs sought to identify the sensitivity of the OUES measurement in 334 
discriminating between children of differing fitness. As the OUES supposedly represents 335 
V̇O2max when maximal exercise efforts cannot be reached 6, it is assumed that the OUES should 336 
follow a similar profiling pattern to V̇O2max and differentiate between patients of differing 337 
clinical and aerobic fitness states.  338 
 339 
When data were categorised into fitness based upon aerobic fitness tertiles, a division shown 340 
to predict mortality in CF 3, a significant difference in V̇O2max was clearly evident both within 341 
and between the groups, but the former was only seen at the highest fitness level. This 342 
observation identifies that differences in aerobic fitness (V̇O2max) can be isolated within 343 
children with CF. However, when represented as aerobic fitness tertiles, differences in the 344 
OUES and OUESGET (Figure 3) were not clearly defined, with a difference only evident 345 
between high-fit and low-fit children and adolescents with CF for OUES at 100%TTE. In 346 
contrast, better discriminatory sensitivity was evident in the CON group, showing differences 347 
in OUES between all tertiles for aerobic fitness. Thus, even though some discriminatory power 348 
may be evident between children and adolescents with CF for high and low aerobic fitness, this 349 
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was only found for OUES at 100%TTE. This suggests that to isolate individuals of differing 350 
fitness status, a measurement of OUES would need to be taken at maximal exercise, as opposed 351 
to a submaximal parameter which can be identified in real-time during a CPET, such as the 352 
GET (characterised by a disproportionate increase in V̇CO2 relative to V̇O2). However, if 353 
participants would be required to reach volitional maximum to produce a maximal OUES 354 
value, clinicians would benefit from utilising V̇O2max as opposed to OUES from peak exercise.  355 
 356 
Since the purpose of the OUES is to provide a measure that is useful in lower functioning 357 
patients, i.e. those unable/unwilling to reach volitional exhaustion, differentiation between 358 
these patients is a key requisite of this CPET parameter, especially at submaximal thresholds. 359 
Unfortunately, this study demonstrates that the OUES does not provide such sensitivity in 360 
children and adolescents with CF. Therefore, despite the OUES showing potential as a clinical 361 
outcome in other paediatric cohorts 6,23, its use as a surrogate of V̇O2max in children and 362 
adolescents with CF is doubtful.  363 
 364 
Previous studies have assessed the validity of the OUES in clinical populations, such as 365 
congestive heart failure 24 and congenital heart disease 25, finding it, to an extent, to be a 366 
suitable, effort-independent, parameter of aerobic fitness. Moreover, two previous studies have 367 
assessed the applicability of the OUES in individuals with CF. One, conducted in 31 adults and 368 
34 healthy controls, concluded that OUES at 80% of test duration is a valid predictor of 369 
maximal aerobic fitness, due to high correlation (r = 0.91) with VO2peak – and therefore may 370 
be a clinically useful submaximal exercise parameter 8. In addition, Bongers et al. 9 sought to 371 
validate the OUES at 50%, 75% and 100% of test duration in 22 children and adolescents with 372 
CF and 22 healthy controls. In contrast to earlier findings in adults, it was concluded to be an 373 
invalid measure, due to limited distinguishing properties and moderate correlations with 374 
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V̇O2max. However, previous studies have analysed OUES at submaximal parameters of time, 375 
without attempts to standardise and individualise exercise intensity, meaning participants may 376 
be exercising in differing metabolic domains, despite matching for exercise duration. Hence, 377 
the current study accounted for these factors, by analysing OUES at submaximal parameters of 378 
intensity, time and individual metabolic thresholds. Furthermore, the groups in the existing 379 
paediatric study 9 were poorly matched, with a significant difference in age evident between 380 
children with CF and healthy counterparts. As previous work has identified age- and sex-381 
related differences in the OUES 7, this may have inadvertently affected results. In addition, 382 
inappropriate ratio-standard scaling methods were utilised, whereas previous research has 383 
shown that allometric procedures are required to remove residual effects of body size from 384 
OUES 12. In order to solely isolate the effects of disease status, the current study deliberately 385 
age- and gender-matched participants, utilising allometric scaling to ensure all influencing 386 
factors were controlled for.  387 
 388 
Given that the OUES is physiologically dependent on metabolic CO2 production (V̇CO2) and 389 
the ratio of pulmonary dead space to tidal volume (VD/VT) 
6, it is prudent to examine which 390 
factors are altered in CF which may account for its weaker relationship with V̇O2max compared 391 
to their healthy counterparts. Whilst a reduced V̇O2max has been reported in children with CF 392 
10,21, no differences exist between CF and CON for the percentage of V̇O2max at which GET (an 393 
indication of the onset of metabolic acidosis 13) occurs 9,10,21,26, suggesting metabolic 394 
development of CO2 is not impaired in CF, and it may be the VD/VT ratio responsible for 395 
reduced OUES – a suggestion proposed, and supported by, previous research 9. Given the 396 
progressive decline in lung function with age in CF, due to bronchiectasis and airway 397 
obstruction 27, such pulmonary impairments may contribute towards elevated dead space 398 
ventilation in CF 28, thus impacting upon OUES. As this decline in lung function is observed 399 
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with age 29, this may account for the discrepancy observed between the current research and 400 
previous OUES analyses in adults with CF 8.  Furthermore, given that the majority of patients 401 
in this study had mild-to-moderate CF (FEV1 > 70% predicted in 31/36 patients), it is unclear 402 
if the OUES will display a differing profile in patients with severe CF (FEV1 < 40% predicted).  403 
 404 
In conclusion, the OUES is not a valid submaximal surrogate of aerobic fitness in children and 405 
adolescents with CF. This research subsequently provides clinical teams with the clear 406 
evidence that  only maximal markers of prognostic value (i.e. V̇O2max) should continue to be 407 
measured in patients with CF. Furthermore, continued research is required to identify 408 
submaximal variables that may hold clinical utility in this patient population when unable or 409 
unwilling to exercise to volitional exhaustion.  410 
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IMAGE LEGENDS 520 
 521 
Figure 1. Comparison of OUES/BSA1.40 values between children and adolescents with CF 522 
(black bars) and healthy age- and gender-matched controls (white bars) at different exercise 523 
thresholds. 524 
 525 
Figure 2. Comparison of V̇O2max, split by V̇O2max tertile (black bars = highest tertile, white 526 
bars = middle tertile, grey bars = lowest tertile), within the CF and healthy control groups.  527 
* Significant (p < 0.01) difference from highest tertile. † Significant (p < 0.01) difference from 528 
middle tertile. § Significant (p < 0.05) difference between groups.  529 
 530 
Figure 3. Comparison of OUES/BSA1.40 at 100% TTE and OUESGET/BSA
1.40 split by V̇O2max 531 
tertile (black bars = highest tertile, white bars = middle tertile, grey bars = lowest tertile), within 532 
the CF and healthy control groups. * Significant (p < 0.05) difference from highest tertile.  533 
† Significant (p < 0.05) difference from middle tertiles. 534 
 535 
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Table 1. Anthropometric, pulmonary function and exercise-related differences between CF and 545 
CON groups.  546 
Variable CF CON p value Effect Size 
Stature (cm) 155.6 (13.5) 159.1 (15.2) 0.32 0.24 
Body mass (kg) 50.15 (15.46) 51.15 (14.49) 0.78 0.07 
BMI (kg.m-2) 20.28 (3.67) 19.91 (4.18) 0.70 0.09 
BSA (m2) 1.46 (0.28) 1.49 (0.28) 0.65 0.11 
aPHV 0.27 (2.70) 0.65 (2.44) 0.89 0.15 
FEV1 (L)* 2.46 (0.97) 2.96 (0.86) 0.07 0.53 
FEV1 (% Predicted)* 88.0 (19.6) 101.9 (12.2) 0.002 0.79 
FVC (L)* 3.10 (1.14) 3.44 (1.02) 0.30 0.31 
FVC (% Predicted)* 94.8 (15.9) 100.2 (12.5) 0.21 0.36 
V̇O2max (L.min-1) 1.74 (0.57) 2.03 (0.88) 0.093 0.39 
V̇O2max (mL.kg-1.min-1) 37.74 (7.74) 39.93 (10.70) 0.32 0.23 
GET (L.min-1) 0.91 (0.28) 1.12 (0.54) 0.035 0.49 
GET (% V̇O2max) 53.4 (9.3) 55.0 (8.0) 0.42 0.18 
HRmax (beats
.min-1) 182 (8) 185 (14) 0.30 0.26 
V̇Emax (L.min-1) 74.66 (35.62) 69.18 (33.45) 0.50 0.16 
RERmax 1.27 (0.23) 1.21 (0.13) 0.22 0.32 
Measures are presented as mean (± SD). Significant mean diffeences are denoted by a bolded 547 
p vlaue. * Unequal groups for pulmonary volumes (CF, n = 36; CON, n = 18). 548 
BMI: body mass index; BSA, body surface area; aPHV, age from peak height velocity; FEV1, 549 
forced expiratory volume in one second; FVC, forced vital capacity; V̇O2max, maximal oxygen 550 
uptake; GET, gas exchange threshold; HR, heart rate; V̇E, minute ventilation; RER, 551 
respiratory exchange ratio.  552 
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Table 2. Correlations at different thresholds between parameters of oxygen uptake and 553 
ventilatory efficicency and V̇O2max relative to body mass.  554 
Oxygen Uptake Parameter CF CON 
OUES/BSA1.40 @ 50% V̇O2max  0.36 (0.040) 0.75 (< 0.001) 
OUES/BSA1.40 @ 50%TTE 0.30 (0.071) 0.76 (< 0.001) 
OUES/BSA1.40 @ 75%V̇O2max 0.33 (0.049) 0.85 (< 0.001) 
OUES/BSA1.40 @ 75%TTE 0.38 (0.023) 0.87 (< 0.001) 
OUES/BSA1.40 @ 100%V̇O2max & TTE 0.47 (0.004)  0.89 (< 0.001) 
OUES/BSA1.40 @ GET 0.35 (0.042) 0.58 (< 0.001) 
OUES/BSA1.40 @ RCP 0.45 (0.007) 0.88 (< 0.001) 
Values are presented as correlation coefficients (r) with p vlaues in parentheses.  555 
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